AL58805 / Advenchen - LARVOL DELTA

A Study of AL58805 in Advanced, Metastatic GYN, STS or Breast Cancers (clinicaltrials.gov) - P1/2 | N=138 | Not yet recruiting | Sponsor: Advenchen Pharmaceuticals, LLC.

dMMR • MSI-H • New P1/2 trial • Breast Cancer • Endometrial Cancer • Oncology • Sarcoma • Soft Tissue Sarcoma • Solid Tumor • MSI

A Study of Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM Cancers (clinicaltrials.gov) - P1/2 | N=138 | Not yet recruiting | Sponsor: Advenchen Pharmaceuticals, LLC.

Monotherapy • New P1/2 trial • P53mut • P53WT • Brain Cancer • Breast Cancer • Endometrial Cancer • Glioblastoma • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Ovarian Cancer • Ovarian Serous Adenocarcinoma • Sarcoma • Small Cell Lung Cancer • Soft Tissue Sarcoma • Solid Tumor

A Study of AL58805 in Patients With Advanced Tumors (clinicaltrials.gov) - P1 | N=40 | Recruiting | Sponsor: Advenchen Laboratories Nanjing Ltd.

New P1 trial